Reduction of DNA binding activity of the GATA-1 transcription factor in the apoptotic process induced by overexpression of PU.1 in Murine erythroleukemia cells

Experimental Cell Research

Volumn 245, Issue 1, 1998, Pages 186-194

  Yamada, Toshiyuki ^a   Kihara Negishi, Fumiko ^a   Yamamoto, Hitomi ^a   Yamamoto, Masayuki ^b   Hashimoto, Yoshiyuki ^a   Oikawa, Tsuneyuki ^a  

^a SASAKI INSTITUTE   (Japan)

^b UNIVERSITY OF TSUKUBA   (Japan)

Author keywords

Apoptosis; GATA 1; Murine erythroleukemia; PU.1

Indexed keywords

TRANSCRIPTION FACTOR; TRANSCRIPTION FACTOR GATA 1;

ANIMAL CELL; APOPTOSIS; ARTICLE; CONTROLLED STUDY; IMMUNOHISTOCHEMISTRY; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN DNA BINDING; PROTEIN EXPRESSION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; RNA ANALYSIS;

ANIMALIA; MURINAE;

EID: 0031773718     PISSN: 00144827     EISSN: None     Source Type: Journal    
DOI: 10.1006/excr.1998.4251     Document Type: Article

References (40)

1. Moreau-Gachelin, F., Tavitian, A., and Tambourin, P. (1988). Spi-1 is a putative oncogene in virally induced murine erythroleukaemias. Nature 331, 277-280.
2. Spiro, C., Gliniak, B., and Kabat, D. (1988). A tagged helper-free Friend virus causes clonal erythroblast immortality by specific proviral integration in the cellular genome. J. Virol. 62, 4129-4135.
3. Moreau-Gachelin, F., Ray, D., Mattei, M. G., Tambourin, P., and Tavitian, A. (1989). The putative oncogene Spi-1: murine chromosomal localization and transcriptional activation in murine acute erythroleukemias. Oncogene 4, 1449-1456.
4. Paul, R., Schuetze, S., Kozak, S. L., and Kabat, D. (1989). A common site for immortalizing proviral integrations in Friend erythroleukemia: molecular cloning and characterization. J. Virol. 63, 4958-4961.
5. Yamada, T., Kondoh, N., Matsumoto, M., Yoshida, M., Maekawa, A., and Oikawa, T. (1997). Overexpression of PU.1 induces growth and differentiation inhibition and apoptotic cell death in murine erythroleukemia cells. Blood 89, 1383-1393.
6. Kihara-Negishi, F., Yamada, T., Kubota, Y., Kondoh, N., Yamamoto, H., Abe, M., Shirai, T., Hashimoto, Y., and Oikawa, T. (1998). Down-regulation of c-myc and bcl-2 gene expression in PU.1-induced apoptosis in murine erythroleukemia cells. Int. J. Cancer 76, 523-530.
7. Myers, R. M., Tilly, K., and Maniatis, T. (1986). Fine structure genetic analysis of a β-globin promoter. Science 232, 613-618.
8. Jarman, A. P., Wood, W. G., Sharpe, J. A., Gourdon, G., Ayyub, H., and Higgs, D. R. (1991). Characterization of the major regulatory element upstream of the human a-globin gene cluster. Mol. Cell. Biol. 11, 4679-4689.
9. Talbot, D., and Grosveld, F. (1991). The 5′HS2 of the globin locus control region enhances transcription through the interaction of a multimeric complex binding at two functionally distinct NF-E2 binding sites. EMBO J. 10, 1391-1398.
10. Strauss, E. C., Andrews, N. C., Higgs, D. R., and Orkin, S. H. (1992). In vivo footprinting of the human a-globin locus upstream regulatory element by guanine and adenine ligation-mediated polymerase chain reaction. Mol. Cell. Biol. 12, 2135-2142.
11. Strauss, E. C., and Orkin, S. H. (1992). In vivo protein-DNA interactions at hypersensitive site 3 of the human β-globin locus control region. Proc. Natl. Acad. Sci. USA 89, 5809-5813.
12. Ellis, J., Talbot, D., Dillon, N., and Grosveld, F. (1993). Synthetic human β-globin 5′HS2 constructs function as locus control regions only in multicopy transgene concatamers. EMBO J. 12, 127-134.
13. Pevny, L., Simon, M. C., Robertson, E., Klein, W. H., Tsai, S. F., D'Agati, V., Orkin, S. H., and Costantini, F. (1991). Erythroid differentiation in chimaeric mice blocked by a targeted mutation in the gene for transcription factor GATA-1. Nature 349, 257-260.
14. Fujiwara, Y., Browne, C. P., Cunniff, K., Goff, S. C., and Orkin, S. H. (1996). Arrested development of embryonic red cell precursors in mouse embryos lacking transcription factor GATA-1. Proc. Natl. Acad. Sci. USA 93, 12355-12358.
15. - embryonic stem cells. Genes Dev. 8, 1184-1197.
16. Weiss, M. J., and Orkin, S. H. (1995). Transcription factor GATA-1 permits survival and maturation of erythroid precursors by preventing apoptosis. Proc. Natl. Acad. Sci. USA 92, 9623-9627.
17. Dignam, J. D., Lebovitz, R. M., and Roeder, R. G. (1983). Accurate transcription initiation by RNA polymerase II in a soluble extract from isolated mammalian nuclei. Nucleic Acids Res. 11, 1475-1489.
18. Yamada, T., Hitomi, Y., Shimizu, K., Ohki, M., and Oikawa, T. (1993). Extinction of T cell receptor alpha-chain gene expression accompanied by loss of the lymphoid enhancer-binding factor 1 (LEF-1) in murine somatic cell hybrids. Mol. Cell. Biol. 13, 1943-1950.
19. Hainaut, P., and Miler, J. (1993). Redox modulation of p53 conformation and sequence-specific DNA binding in vivo. Cancer Res. 53, 4469-4473.
20. Krek, W., Ewen, M. E., Shirodker, S., Arany, Z., Kaelin, W. G. Jr., and Livingston, D. M. (1994). Negative regulation of the growth-promoting transcription factor E2F-1 by a stably bound cyclin A-dependent protein kinase. Cell 78, 161-172.
21. Andrews, N. C., Kotkow, K. J., Ney, P. A., Erdjument-Bromage, H., Tempst, P., and Orkin, S. H. (1993). The ubiquitous subunit of erythroid transcription factor NF-E2 is a small basic-leucine zipper protein related to the v-maf oncogene. Proc. Natl. Acad. Sci. USA 90, 11488-11492.
22. Igarashi, K., Itoh, K., Motohashi, H., Hayashi, N., Matuzaki, Y., Nakauchi, H., Nishizawa, M., and Yamamoto, M. (1995). Activity and expression of murine small Maf family protein MafK. J. Biol. Chem. 270, 7615-7624.
23. Walters, M., and Martin, D. I. K. (1992). Functional erythroid promoters created by interaction of the transcription factor GATA-1 with CACCC and AP-1/NFE-2 elements. Proc. Natl. Acad. Sci. USA 89, 10444-10448.
24. Crossley, M., and Orkin, S. H. (1994). Phosphorylation of the erythroid transcription factor GATA-1. J. Biol. Chem. 269, 16589-16596.
25. Blobel, G. A., and Orkin, S. H. (1996). Estrogen-induced apoptosis by inhibition of the erythroid transcription factor GATA-1. Mol. Cell. Biol. 16, 1687-1694.
26. Cullen, M. E., and Patient, R. K. (1997). GATA-1 DNA binding activity is down-regulated in late S phase in erythroid cells. J. Biol. Chem. 272, 2464-2469.
27. Dubart, A., Roméo, P. H., Vainchenker, W., and Dumenil, D. (1996). Constitutive expression of GATA-1 interferes with the cell-cycle regulation. Blood 87, 3711-3721.
28. Lu, S. J., Rowan, S., Bani, M. R., and Ben-David, Y. (1994). Retroviral integration within the Fli-2 locus results in inactivation of the erythroid transcription factor NF-E2 in Friend erythroleukemia: Evidence that NF-E2 is essential for globin expression. Proc. Natl. Acad. Sci. USA 91, 8398-8402.
29. Kotkow, K. J., and Orkin, S. H. (1995). Dependence of globin gene expression in mouse erythroleukemia cells on the NF-E2 heterodimer. Mol. Cell. Biol. 15, 4640-4647.
30. Shivdasani, R. A., Rosenblatt, M. F., Zucker-Franklin, D., Jackson, C. W., Hunt, P., Saris, C. J. M., and Orkin, S. H. (1995). Transcription factor NF-E2 is required for platelet formation independent of the actions of thrombopoietin/MGDF in megakaryocyte development. Cell 81, 695-704.
31. Shivdasani, R. A., and Orkin, S. H. (1995). Erythropoiesis and globin gene expression in mice lacking the transcription factor NF-E2. Proc. Natl. Acad. Sci. USA 92, 8690-8694.
32. Nuez, B., Michalovich, D., Bygrave, A., Ploemacher, R., and Grosveld, F. (1995). Defective haematopoiesis in fetal liver reulting from inactivation of the EKLF gene. Nature 375, 316-318.
33. Perkins, A. C., Sharpe, A. H., and Orkin, S. H. (1995). Lethal β-thalassaemia in mice lacking the erythroid CACCC-transcription factor EKLF. Nature 375, 318-322.
34. Warren, A. J., Colledge, W. H., Carlton, M. B. L., Evans, M. J., Smith, A. J. H., and Rabbitts, T. H. (1994). The oncogenic cysteine-rich LIM domain protein Rbtn2 is essential for erythroid development. Cell 78, 45-57.
35. Aplan, P. D., Nakahara, K., Orkin, S. H., and Kirsch, I. R. (1992). The SCL gene product: a positive regulator of erythroid differentiation. EMBO J. 11, 4073-4081.
36. Shivdasani, R. A., Mayer, E. L., and Orkin, S. H. (1995). Absence of blood formation in mice lacking the T-cell leukaemia oncoprotein tal-1/SCL. Nature 373, 432-434.
37. Robb, L., Lyons, I., Li, R., Hartley, L., Köntgen, F., Harvey, R. P., Metcalf, D., and Begley, C. G. (1995). Absence of yolk sac hematopoiesis from mice with a targeted disruption of the scl gene. Proc. Natl. Acad. Sci. USA 92, 7075-7079.
38. Scott, E. W., Simon, M. C., Anastasi, J., and Singh, H. (1994). Requirement of transcription factor PU.1 in the development of multiple hematopoietic lineages. Science 265, 1573-1577.
39. McKercher, S. R., Torbett, B. E., Anderson, K. L., Henkel, G. W., Vestal, D. J., Baribault, H., Klemsz, M., Feeney, A. J., Wu, G. E., Paige, C. J., and Maki, R. A. (1996). Targeted disruption of the PU.1 gene results in multiple hematopoietic abnormalities. EMBO J. 15, 5647-5658.
40. Schuetze, S., Stenberg, P. E., and Kabat, D. (1993). The Ets-related transcription factor PU.1 immortalizes erythroblasts. Mol. Cell. Biol. 13, 5670-5678.